Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-10-13
1992-11-24
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514 50, 514261, 514269, A61K 3170, A61K 3152, A61K 31505
Patent
active
051661403
ABSTRACT:
A method involving the administration of nucleoside analogs to circumvent resistance attributable to the enhanced DNA repair capacity of cancer cells is described. The nucleoside analogs function as suicide substrates for DNA repair enzymes. A method of screening nucleoside analogs for utility as antitumor agents and a screening assay to individual recurrent tumors is described.
REFERENCES:
Kornberg, et al., "Studies on the Replication of DNA by DNA Polymerases" Cold Spring Harbor Symp. Quart. Biol. 28:9-19 (1963).
Newman, et al.,"Mechanisms of Cross-Resistance to Methotrexate and 5-fluorouracil in an A2780 Human Ovarian Carcinoma Cell Subline Resistant to Cisplatin", Biochemical Pharmacology 37:443-447 (1988).
Scanlon, et al, "Overexpression of DNA Replication and Repair Enzymes in Cisplatin-Resistant Human Colon Carcinoma HCT8 Cells and Circumvention by Azidothymidine", Cancer Communications 1(4):269-275 (1989).
Scanlon, et al., "Potentiation of Azidothymidine Cytotoxicity in Cisplatin-resistant Human Ovarian Carcinoma Cells", Cancer Communications 2(10):339-343 (1990).
Scanlon Kevin J.
Sowers Lawrence C.
City of Hope
Irons Edward S.
Rollins John W.
LandOfFree
Use of certain nucleoside analogs to attenuate cancer cell resis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of certain nucleoside analogs to attenuate cancer cell resis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of certain nucleoside analogs to attenuate cancer cell resis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-921726